Cargando…
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib
BACKGROUND: Early detection of adverse effects of novel therapies and understanding of their mechanisms could improve the safety and efficiency of drug development. We have retrospectively applied large-scale proteomics to blood samples from ILLUMINATE (Investigation of Lipid Level Management to Und...
Autores principales: | Williams, Stephen A., Murthy, Ashwin C., DeLisle, Robert K., Hyde, Craig, Malarstig, Anders, Ostroff, Rachel, Weiss, Sophie J., Segal, Mark R., Ganz, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839936/ https://www.ncbi.nlm.nih.gov/pubmed/28974520 http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028213 |
Ejemplares similares
-
Impact of Kidney Function on the Blood Proteome and on Protein Cardiovascular Risk Biomarkers in Patients With Stable Coronary Heart Disease
por: Yang, Joseph, et al.
Publicado: (2020) -
Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach
por: Fan, Shengjun, et al.
Publicado: (2012) -
Torcetrapib-induced blood pressure elevation is independent of CETP inhibition and is accompanied by increased circulating levels of aldosterone
por: Forrest, M J, et al.
Publicado: (2008) -
Unforeseen Mentor
por: Constantino, Eduardo
Publicado: (2021) -
The unforeseen orbital tumor
por: Singh, Srishti, et al.
Publicado: (2020)